Literatur
Maron BJ, Mc Kenna WJ, Danielson GK, et al (2003) ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24: 1965–1991
Kimura A (2008) Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 72 [Suppl A]: A38–A48
Shirani J, Pick R, Roberts WC, et al (2000) Morphology and significance of the let ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 35: 36–44
Olivotto I, Cecchi F, Casey S, et al (2001) Impact of atrial fibrillation on the clinical corse of hypertrophic cardiomyopathy. Circulation 104: 2517–2524
Biagini E, Coccolo F, Ferlito M, et al (2005) Dilated-hypokinetic evolution of hypertrophic cardiomyopathy. J Am Coll Cardiol 46: 1543–1550
Stöllberger C, Finsterer J (2001) Echokardiographie bei Speichererkrankungen und neuromuskulären Erkrankungen. Wien Klin Wochenschr 113: 408–415
Linhart A, Elliott PM (2007) The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart 93: 528–535
Finsterer J, Stöllberger C (2008) Primary myopathies and the heart. Scand Cardiovasc J 42: 9–24
Stöllberger C, Finsterer J (2004) Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr 17: 91–100
Finsterer J, Stöllberger C (2008) Neuromuscular disorders associated with apical hypertrophic cardiomyopathy. Acta Cardiol (in press)
Winkler WB, Stöllberger C, Finsterer J (2006) Right-sided hypertrophic cardiomyopathy with generalised wasting. J Cardiovasc Electrophysiol 17: 1145–1146
van der Wall EE, Bax JJ, Schalj MJ (2008) Detection of apical hypertrophic cardiomyopathy; which is he appropriate imaging modality. Int J Cardiovasc Imaging 24: 683–685
Adabag AS, Maron BJ, Appelbaum E, et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51: 1369–1374
Smedira NG, Lytle BW, Lever HM, et al (2008) Current effectiveness and risks of isolated septal myektomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 85: 127–133
Sorajja P, Valeti U, Nishimura RA, et al (2008) Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 118: 131–139
Maron BJ, Spirito P, Shen WK, et al (2007) Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298: 405–412
Maron MS, Olivotta I, Betochi S, et al (2003) Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 348: 295–303
Vaglio JC, Ommen SR, Nishimura RA, et al (2008) Clinical characteristics and outcomes of patients with hypertrophic cardiomyopathy with latent obstruction. Am Heart J 156: 342–347
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stöllberger, C., Finsterer, J. Hypertrophe Kardiomyopathie. Wiener Klin. Wochenschr. Educ. 4, 1–13 (2009). https://doi.org/10.1007/s11812-009-0048-6
Issue Date:
DOI: https://doi.org/10.1007/s11812-009-0048-6